FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Firefly Value Partners, LP 		2. Issuer Name and Ticker or Trading Symbol

NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ [ NTII ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

551 FIFTH AVE, 36TH FLOOR 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/22/2009
(Street)

NEW YORK, NY 10176
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.001   10/22/2009     P    165007   A $.9083   2752560   I   By FVP Master Fund, L.P.   (1)
Common Stock, par value $0.001   10/22/2009     P    135442   A $.9083   2259385   I   By FVP US-Q, LP   (2)
Common Stock, par value $0.001   10/26/2009     P    99365   A $.8999   2851925   I   By FVP Master Fund, L.P.   (1)
Common Stock, par value $0.001   10/26/2009     P    81561   A $.8999   2340946   I   By FVP US-Q, LP   (2)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  Firefly Value Partners, LP ("Firefly Partners") serves as investment manager to FVP Master Fund, L.P. (the "FVP Master Fund"), the direct owner of the subject securities. FVP GP, LLC ("FVP GP") serves as the general partner of the FVP Master Fund and Firefly Management Company GP, LLC ("Firefly Management") serves as the general partner of Firefly Partners. Messrs. Ryan Heslop and Ariel Warszawski are the managing members of FVP GP and Firefly Management. Each Reporting Person disclaims beneficial ownership of all securities reported herein, except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934 ("Exchange Act") or for any other purpose.
( 2)  Firefly Partners serves as investment manager to FVP US-Q, LP (the "FVP Fund"), the direct owner of the subject securities. FVP GP serves as the general partner of the FVP Fund and Firefly Management serves as the general partner of Firefly Partners. Messrs. Ryan Heslop and Ariel Warszawski are the managing members of FVP GP and Firefly Management. Each Reporting Person disclaims beneficial ownership of all securities reported herein, except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Firefly Value Partners, LP
551 FIFTH AVE, 36TH FLOOR
NEW YORK, NY 10176
X

Firefly Management CO GP, LLC
551 FIFTH AVE, 36TH FLOOR
NEW YORK, NY 10176
X

FVP GP, LLC
551 FIFTH AVE, 36TH FLOOR
NEW YORK, NY 10176
X

FVP Master Fund LP
551 FIFTH AVE, 36TH FLOOR
NEW YORK, NY 10176
X

FVP US-Q LP
551 FIFTH AVE, 36TH FLOOR
NEW YORK, NY 10176
X

Warszawski Ariel
551 FIFTH AVE, 36TH FLOOR
NEW YORK, NY 10176
X

Heslop Ryan
551 FIFTH AVE, 36TH FLOOR
NEW YORK, NY 10176
X


Signatures
/s/ Ariel Warszawski Ariel Warszawski, for himself, as Managing Member of FVP GP (for itself and as general partner of the FVP Master Fund and the FVP Fund) and of Firefly Management (for itself and as general partners of Firefly Partners) 10/26/2009
** Signature of Reporting Person Date

/s/ Ryan Heslop 10/26/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Neurobiological Charts.
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Neurobiological Charts.